Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors. [electronic resource]
Producer: 20190204Description: 1900-1901 p. digitalISSN:- 1473-5571
- Drug Resistance, Viral
- HIV Infections -- drug therapy
- HIV Integrase -- genetics
- HIV Integrase Inhibitors -- administration & dosage
- HIV-1 -- enzymology
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- Male
- Middle Aged
- Mutation, Missense
- Oxazines
- Piperazines
- Pyridones
- Sustained Virologic Response
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.